clinical trials glp-1 Could medications help slow cancer progression?⁣ ⁣ A new Cleveland Clinic study found those taking GLP-1s were less likely to develop stage IV disease in several cancer types, when compared to SGLTi and GLP-1 in HF

PubMed, doi:10.1007/s11033-012-2023-z

It can take up to 16 weeks or more to reach your maintenance dose

Reported Positive Outcomes Common positive experiences include: Feeling fuller between meals, especially when taken before breakfast or lunch Less mindless snacking or emotional eating, particularly in the evening hours Gentle, steady weight reduction over several weeksnot overnight drops Better digestion and regularity No energy crashes or stimulant-related side effects For some individuals, the impact was not dramatic in the first few days, but became more noticeable with consistent use over two to three weeks

AOD-9604 acts on adipocyte lipolysis pathways through beta-3 adrenergic receptor signalling, with effects measured at the fat cell level

, ,